{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:17:51Z","timestamp":1769512671245,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11916-022-01059-1","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T12:04:16Z","timestamp":1655553856000},"page":"567-574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Advocacy for Migraine Relief: Strategic Planning to Eliminate the Burden"],"prefix":"10.1007","volume":"26","author":[{"given":"Teshamae S.","family":"Monteith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,18]]},"reference":[{"issue":"1","key":"1059_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41572-021-00328-4","volume":"8","author":"MD Ferrari","year":"2022","unstructured":"Ferrari MD, Goadsby PJ, Burstein R, Kurth T, Ayata C, Charles A, et al. Migraine Nat Rev Dis Primers. 2022;8(1):2.","journal-title":"Migraine Nat Rev Dis Primers"},{"issue":"9","key":"1059_CR2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1526-4610.2004.04167.x","volume":"44","author":"SJ Tepper","year":"2004","unstructured":"Tepper SJ, Dahlof CG, Dowson A, Newman L, Mansbach H, Jones M, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study. Headache. 2004;44(9):856\u201364.","journal-title":"Headache"},{"issue":"5","key":"1059_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343\u20139.","journal-title":"Neurology"},{"issue":"2","key":"1059_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/0142159X.2017.1245853","volume":"39","author":"M Hubinette","year":"2017","unstructured":"Hubinette M, Dobson S, Scott I, Sherbino J. Health advocacy. Med Teach. 2017;39(2):128\u201335.","journal-title":"Med Teach"},{"issue":"2","key":"1059_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/head.13209","volume":"58","author":"WB Young","year":"2018","unstructured":"Young WB. De-stigmatizing migraine - with words. Headache. 2018;58(2):319\u201321.","journal-title":"Headache"},{"issue":"3","key":"1059_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.nrl.2011.05.006","volume":"27","author":"E Garcia-Albea","year":"2012","unstructured":"Garcia-Albea E. Migraine associated with conversion symptoms (Babinski\u2019s migraine): evaluation of a series of 43 cases. Neurologia. 2012;27(3):125\u201335.","journal-title":"Neurologia"},{"key":"1059_CR7","first-page":"305","volume":"20","author":"J De la Babinski","year":"1890","unstructured":"De la Babinski J. migraine ophtalmique hyst\u00e9rique. Archives de Neurologie. 1890;20:305\u201335.","journal-title":"Archives de Neurologie"},{"issue":"10","key":"1059_CR8","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1111\/j.1526-4610.2012.02255.x","volume":"52","author":"TP Jurgens","year":"2012","unstructured":"Jurgens TP, May A. Does the neurobiology of migraine make migraine patients \u201cdifficult\u201d? Headache. 2012;52(10):1607\u20138.","journal-title":"Headache"},{"key":"1059_CR9","unstructured":"Foundation NH. The Journey from Headache Week to National Migraine and Headache Awareness Month [Available from: https:\/\/headaches.org\/2021\/05\/31\/the-journey-from-headache-week-to-migraine-and-headache-awareness-month\/."},{"key":"1059_CR10","doi-asserted-by":"crossref","unstructured":"Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American migraine study. Cephalalgia. 1996;16(4):231\u20138; discussion 15.","DOI":"10.1046\/j.1468-2982.1996.1604231.x"},{"issue":"Suppl 1","key":"1059_CR11","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1526-4610.2005.4501001.x","volume":"45","author":"RB Lipton","year":"2005","unstructured":"Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache. 2005;45(Suppl 1):S3\u201313.","journal-title":"Headache"},{"issue":"11","key":"1059_CR12","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"GBDH Collaborators","year":"2018","unstructured":"Collaborators GBDH. Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954\u201376.","journal-title":"Lancet Neurol"},{"key":"1059_CR13","unstructured":"Coronavirus Resource Center. John Hopkins University of Medicine.\u00a02022."},{"issue":"27","key":"1059_CR14","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"5","key":"1059_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403\u201316.","journal-title":"N Engl J Med"},{"key":"1059_CR16","doi-asserted-by":"crossref","unstructured":"Sadoff J, Gray G, Vandebosch A, Cardenas V, Shukarev G, Grinsztejn B, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021;384(23):2187\u2013201.","DOI":"10.1056\/NEJMoa2101544"},{"key":"1059_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103722","volume":"74","author":"RR Deer","year":"2021","unstructured":"Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, Anzalone AJ, et al. Characterizing Long COVID: deep phenotype of a complex condition. EBioMedicine. 2021;74:103722.","journal-title":"EBioMedicine"},{"key":"1059_CR18","doi-asserted-by":"crossref","unstructured":"Huang Y, Pinto MD, Borelli JL, Mehrabadi MA, Abrihim H, Dutt N, et al. COVID symptoms, symptom clusters, and predictors for becoming a long-hauler: looking for clarity in the haze of the pandemic. medRxiv. 2021.","DOI":"10.1101\/2021.03.03.21252086"},{"key":"1059_CR19","unstructured":"National Center for Health Statistics CfDCaP. Data Brief 329. Drug overdose deaths in the United States, 1999\u20132017 2019 [Available from: https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db329_tables-508.pdf#page=4."},{"issue":"3","key":"1059_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.amepre.2019.04.022","volume":"57","author":"C Janakiram","year":"2019","unstructured":"Janakiram C, Fontelo P, Huser V, Chalmers NI, Lopez Mitnik G, Brow AR, et al. Opioid prescriptions for acute and chronic pain management among Medicaid beneficiaries. Am J Prev Med. 2019;57(3):365\u201373.","journal-title":"Am J Prev Med"},{"issue":"8","key":"1059_CR21","volume":"12","author":"UK Patel","year":"2020","unstructured":"Patel UK, Malik P, Shah D, Sharma A, Bhela J, Chauhan B, et al. The opioid epidemic and primary headache disorders: a nationwide population-based study. Cureus. 2020;12(8):e9743.","journal-title":"Cureus"},{"issue":"3","key":"1059_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1468-2982.2009.01913.x","volume":"30","author":"AI Scher","year":"2010","unstructured":"Scher AI, Lipton RB, Stewart WF, Bigal M. Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia. 2010;30(3):321\u20138.","journal-title":"Cephalalgia"},{"key":"1059_CR23","doi-asserted-by":"crossref","unstructured":"Miller J, Koons L, Longyhore D. Opioid free treatment algorithm for ED headache management: effect on revisit rate. Am J Emerg Med. 2020;38(1):28\u201332.","DOI":"10.1016\/j.ajem.2019.03.053"},{"key":"1059_CR24","unstructured":"SERVICES USDOHAH. Strategy to combat opioid abuse, misuse, and overdose. 2018."},{"key":"1059_CR25","unstructured":"National Institutes of Health. NIH HEAL Initiative 2021 Annual Report [updated June 8, 2021 Available from: https:\/\/heal.nih.gov\/about\/research-plan#references."},{"issue":"6","key":"1059_CR26","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.1526-4610.2008.01159.x","volume":"48","author":"BJ Theeler","year":"2008","unstructured":"Theeler BJ, Mercer R, Erickson JC. Prevalence and impact of migraine among US Army soldiers deployed in support of Operation Iraqi Freedom. Headache. 2008;48(6):876\u201382.","journal-title":"Headache"},{"key":"1059_CR27","volume-title":"Board of Directors of the American Headache S","author":"J Ailani","year":"2021","unstructured":"Ailani J, Burch RC, Robbins MS. Board of Directors of the American Headache S. Update on integrating new migraine treatments into clinical practice. Headache: The American Headache Society Consensus Statement; 2021."},{"issue":"3","key":"1059_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0333102421989247","volume":"41","author":"HC Diener","year":"2021","unstructured":"Diener HC, Ashina M, Durand-Zaleski I, Kurth T, Lanteri-Minet M, Lipton RB, et al. Health technology assessment for the acute and preventive treatment of migraine: a position statement of the International Headache Society. Cephalalgia. 2021;41(3):279\u201393.","journal-title":"Cephalalgia"},{"issue":"4","key":"1059_CR29","first-page":"435","volume":"27","author":"TV Newman","year":"2021","unstructured":"Newman TV, Munshi KD, Neilson LM, Good CB, Swart ECS, Huang Y, et al. Health care utilization and costs associated with switching from DPP-4i to GLP-1RA or SGLT2i: an observational cohort study. J Manag Care Spec Pharm. 2021;27(4):435\u201343.","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"1059_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s10194-019-1044-6","volume":"20","author":"RE Shapiro","year":"2019","unstructured":"Shapiro RE, Hochstetler HM, Dennehy EB, Khanna R, Doty EG, Berg PH, et al. Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials. J Headache Pain. 2019;20(1):90.","journal-title":"J Headache Pain"},{"issue":"3","key":"1059_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/WCO.0000000000000806","volume":"33","author":"D Moreno-Ajona","year":"2020","unstructured":"Moreno-Ajona D, Perez-Rodriguez A, Goadsby PJ. Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment? Curr Opin Neurol. 2020;33(3):309\u201315.","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"1059_CR32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/0333102416678382","volume":"37","author":"Z Hepp","year":"2017","unstructured":"Hepp Z, Dodick DW, Varon SF, Chia J, Matthew N, Gillard P, et al. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis. Cephalalgia. 2017;37(5):470\u201385.","journal-title":"Cephalalgia"},{"key":"1059_CR33","doi-asserted-by":"crossref","unstructured":"Hatcher-Martin JM, Busis NA, Cohen BH, Wolf RA, Jones EC, Anderson ER, et al. American Academy of Neurology Telehealth Position Statement. Neurology. 2021.","DOI":"10.1212\/WNL.0000000000012185"},{"issue":"5","key":"1059_CR34","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/head.14110","volume":"61","author":"CC Chiang","year":"2021","unstructured":"Chiang CC, Halker Singh R, Lalvani N, Shubin Stein K, Henscheid Lorenz D, Lay C, et al. Patient experience of telemedicine for headache care during the COVID-19 pandemic: an American Migraine Foundation survey study. Headache. 2021;61(5):734\u20139.","journal-title":"Headache"},{"issue":"1","key":"1059_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/head.14024","volume":"61","author":"R Burch","year":"2021","unstructured":"Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: updated age, sex, and socioeconomic-specific estimates from government health surveys. Headache. 2021;61(1):60\u20138.","journal-title":"Headache"},{"issue":"9","key":"1059_CR36","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/jamaneurol.2019.1663","volume":"76","author":"JM Nagata","year":"2019","unstructured":"Nagata JM, Weiser SD, Gooding HC, Garber AK, Bibbins-Domingo K, Palar K. Association between food insecurity and migraine among US young adults. JAMA Neurol. 2019;76(9):1121\u20132.","journal-title":"JAMA Neurol"},{"issue":"3","key":"1059_CR37","first-page":"195","volume":"86","author":"T To","year":"1995","unstructured":"To T, Wu K. Health care utilization and disability of migraine: the Ontario Health Survey. Can J Public Health. 1995;86(3):195\u20139.","journal-title":"Can J Public Health"},{"key":"1059_CR38","unstructured":"Foundation AM. AHS & AMF Commitment on the Impact of Recent National Events, Racism, and Healthcare Disparities 2020 [updated June 5, ,2020 Available from: https:\/\/americanmigrainefoundation.org\/resource-library\/racism-and-healthcare-disparities."},{"key":"1059_CR39","unstructured":"Foundation AM. AMF stands against racism, violence and xenophobia 2021 [updated March 20, 2021 Available from: https:\/\/americanmigrainefoundation.org\/resource-library\/stands-against-racism-violence-xenophobia\/."},{"issue":"Pt 1","key":"1059_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/brain\/awn321","volume":"132","author":"PJ Goadsby","year":"2009","unstructured":"Goadsby PJ. The vascular theory of migraine\u2013a great story wrecked by the facts. Brain. 2009;132(Pt 1):6\u20137.","journal-title":"Brain"},{"issue":"2","key":"1059_CR41","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97(2):553\u2013622.","journal-title":"Physiol Rev"},{"issue":"5","key":"1059_CR42","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1526-4610.2011.01892.x","volume":"51","author":"PC Tfelt-Hansen","year":"2011","unstructured":"Tfelt-Hansen PC, Koehler PJ. One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010. Headache. 2011;51(5):752\u201378.","journal-title":"Headache"},{"issue":"Pt 1","key":"1059_CR43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/brain\/awt320","volume":"137","author":"FH Maniyar","year":"2014","unstructured":"Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2014;137(Pt 1):232\u201341.","journal-title":"Brain"},{"key":"1059_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s10194-015-0495-7","volume":"16","author":"LH Schulte","year":"2015","unstructured":"Schulte LH, Jurgens TP, May A. Photo-, osmo- and phonophobia in the premonitory phase of migraine: mistaking symptoms for triggers? J Headache Pain. 2015;16:14.","journal-title":"J Headache Pain"},{"key":"1059_CR45","unstructured":"Foundation UP. Advocacy round-up. 2020"},{"key":"1059_CR46","unstructured":"(NINDS) NIoNDaS. Request for information: soliciting input on areas of health disparities and inequities in neurological disease and\/or care in the United States across the lifespan 2021 [Available from: https:\/\/grants.nih.gov\/grants\/guide\/notice-files\/NOT-NS-20-026.html."},{"key":"1059_CR47","doi-asserted-by":"publisher","first-page":"215013272199404","DOI":"10.1177\/2150132721994040","volume":"12","author":"ME Tarver","year":"2021","unstructured":"Tarver ME. Race and ethnicity in real-world data sources: considerations for medical device regulatory efforts. J Prim Care Community Health. 2021;12:2150132721994040.","journal-title":"J Prim Care Community Health"},{"issue":"6","key":"1059_CR48","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/head.14134","volume":"61","author":"A Pace","year":"2021","unstructured":"Pace A, Orr SL, Rosen NL, Safdieh JE, Cruz GB, Sprouse-Blum AS. The current state of headache medicine education in the United States and Canada: an observational, survey-based study of neurology clerkship directors and curriculum deans. Headache. 2021;61(6):854\u201362.","journal-title":"Headache"},{"issue":"11","key":"1059_CR49","doi-asserted-by":"publisher","first-page":"907","DOI":"10.7326\/0003-4819-139-11-200312020-00009","volume":"139","author":"LA Cooper","year":"2003","unstructured":"Cooper LA, Roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR. Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med. 2003;139(11):907\u201315.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1059_CR50","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1212\/WNL.0b013e31827b19e1","volume":"80","author":"T Wijeratne","year":"2013","unstructured":"Wijeratne T, DePold HA. Residency training: advocacy training in neurology: lessons from the Palatucci Advocacy Leadership Forum. Neurology. 2013;80(1):e1-3.","journal-title":"Neurology"},{"issue":"11","key":"1059_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11910-020-01073-z","volume":"20","author":"KN Arca","year":"2020","unstructured":"Arca KN, Starling AJ. Advocacy in Headache Medicine: Tips at the bedside, the institutional level, and beyond. Curr Neurol Neurosci Rep. 2020;20(11):52.","journal-title":"Curr Neurol Neurosci Rep"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-022-01059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-022-01059-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-022-01059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:19:10Z","timestamp":1744201150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-022-01059-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,18]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1007\/s11916-022-01059-1","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,18]]},"assertion":[{"value":"20 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Springer Nature\u2019s version of this paper was updated to correct the grammatical error in 'Introduction' section.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Teshamae Monteith has received personal compensation for serving on advisory boards for Biohaven, Allegan\/Abbvie, Lundbeck, Amgen, Teva, and Impel Neuropharmaceuticals. She has also served as a site principal investigator without direct compensation for Teva, Eli Lilly, Electrocore, Amgen, and Novartis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}